Research News

Single mutation leads to big effects in autism-related gene

  • Posted on: 6 April 2020
  • By: admin

A new study in Neuron offers clues to why autism spectrum disorder (ASD) is more common in boys than in girls. National Institutes of Health scientists found that a single amino acid change in the NLGN4 gene, which has been linked to autism symptoms, may drive this difference in some cases. The study was conducted at NIH’s National Institute of Neurological Disorders and Stroke (NINDS).

FDA Coordinates National Effort to Develop Blood-Related Therapies for COVID-19

  • Posted on: 6 April 2020
  • By: admin

The U.S. Food and Drug Administration continues to play a critical role in accelerating medical countermeasures to treat and prevent COVID-19. As part of the response to this pandemic, the agency is taking the lead on a national effort to facilitate the development of, and access to, two investigational therapies derived from human blood. These are called convalescent plasma and hyperimmune globulin and are antibody-rich blood products made from blood donated by people who have recovered from the virus.

TB Vaccine could be a valuable weapon in COVID-19 Fight : Researchers

  • Posted on: 3 April 2020
  • By: admin

The tuberculosis (TB) vaccine, Bacillus Calmette-Guerin (BCG), could be a potential weapon in combatting the deadly coronavirus according to findings published by NYIT College of Osteopathic Medicine (NYITCOM) researchers, led by Gonzalo Otazu, Ph.D., assistant professor of biomedical sciences.

Assam doctor died after taking hydroxychloroquine as prophylaxis

Assamese Doctor probably died of heart attack after taking anti-malarial drug as prophylaxis against novel corona virus (COVID-19). Anti-malarial drug, hydroxychloroquine, is used to prevent and treat acute attacks of malaria. It is also used to treat discoid or systemic lupus erythematosus and rheumatoid arthritis in patients whose symptoms have not improved with other treatments.

Kidney patients are more vulnerable to COVID-19 infections

  • Posted on: 27 March 2020
  • By: admin

The COVID-19 pandemic is throwing up unique challenges for health systems. It presents particular challenges for patients who receive regular haemodialysis. These patients with damaged kidneys, also known as uremic patients, are particularly vulnerable to infection and may exhibit greater variations in clinical symptoms and infectivity. 

Antimalarial drug is very effective against COVID-19

  • Posted on: 21 March 2020
  • By: PharmaTutor News

Scientists from France conducted a small clinical trials and reported that hydroxychloroquine, an antimalarial medicine, treatment is significantly associated with viral load reduction or disappearance in COVID-19 patients and they also reported that azithromycin along with hydroxychloroquine can faster the recovery.

COVID-19 is different in characteristics in children than adult : Research

  • Posted on: 18 March 2020
  • By: PharmaTutor News

In the early days of a COVID‐19 infection outbreak, pediatric patients were rather rare, who were thought to be not susceptible to it. However, along with the emerging of familial aggregation, children suffered from COVID‐19 infection were gradually appeared. It is reported by researchers that Clinical and CT (computed tomography) features in pediatric patients with COVID‐19 infection are different than adults. The study was conducted by Dr. Jianbo Shao, MD, Department of Imaging Center, Wuhan Children's Hospital and team. And it is published in Pediatric Pulmonology on 5th March, 2020.